← Open Payments lookup

JOHN DAHUNSI: Open Payments

NPI 1386378735 · OLNEY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,107 in 52 payments from 11 companies in 2025. Trend: 2023 $813 · 2024 $1,297 · 2025 $1,107

Food & beverage: $1,107
CompanyPaymentsAmount
ABBVIE INC.12$258
Janssen Pharmaceuticals, Inc9$168
Lundbeck LLC8$143
Vanda Pharmaceuticals Inc.4$122
E.R. Squibb & Sons, L.L.C.4$94
Otsuka America Pharmaceutical, Inc.3$71
Teva Pharmaceuticals USA, Inc.4$69
Neurocrine BioSciences, Inc.2$63
Supernus Pharmaceuticals, Inc.3$54
Corium, LLC2$41

Products named: VRAYLAR, REXULTI, COBENFY, SPRAVATO, INVEGA SUSTENNA, HETLIOZ, INGREZZA, FANAPT.

Industry payments across MD — which companies pay providers there.